Literature DB >> 21570254

Early changes in left ventricular long-axis function in Friedreich ataxia: relation with the FXN gene mutation and cardiac structural change.

Philip M Mottram1, Martin B Delatycki, Lesley Donelan, John S Gelman, Louise Corben, Roger E Peverill.   

Abstract

OBJECTIVE: Friedreich ataxia (FRDA) is an autosomal recessive condition due to a GAA triplet expansion in the FXN gene that causes increased left ventricular (LV) wall thickness and can progress to LV systolic dysfunction. However, the changes in myocardial function that occur before a reduction in LV ejection fraction are incompletely understood.
METHODS: LV long-axis function was assessed by measurement of tissue Doppler imaging (TDI) peak systolic (S`), early diastolic (E`), and atrial velocities (A`) at the septal and lateral borders of the mitral annulus in 60 subjects homozygous for a GAA expansion in the FXN gene who had preserved LV ejection fraction. Comparison was made with 60 sex- and age-matched controls. TDI velocities at 5 years were compared with baseline values in 17 FRDA subjects with follow-up studies who still had preserved ejection fraction.
RESULTS: S` and E` were reduced in FRDA subjects at both the septal and the lateral mitral annular borders. Lateral E` was independently and inversely related to age, blood pressure, septal wall thickness, and the number of GAA repeats in the smaller allele of the FXN gene, whereas septal E` was not correlated with GAA repeat number. At 5 years, there was a reduction in lateral S` and E` but no change in septal TDI velocities.
CONCLUSION: Subjects with FRDA have impairment of septal and lateral long-axis LV function, but there also seem to be regional differences in the effects of this condition that are at least partly related to the degree of genetic abnormality.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570254     DOI: 10.1016/j.echo.2011.04.004

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  10 in total

1.  Cardiomyopathy of Friedreich's ataxia (FRDA).

Authors:  R M Payne; R E Peverill
Journal:  Ir J Med Sci       Date:  2012-02-29       Impact factor: 1.568

2.  An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.

Authors:  Eppie M Yiu; Geneieve Tai; Roger E Peverill; Katherine J Lee; Kevin D Croft; Trevor A Mori; Barbara Scheiber-Mojdehkar; Brigitte Sturm; Monika Praschberger; Adam P Vogel; Gary Rance; Sarah E M Stephenson; Joseph P Sarsero; Creina Stockley; Chung-Yung J Lee; Andrew Churchyard; Marguerite V Evans-Galea; Monique M Ryan; Paul J Lockhart; Louise A Corben; Martin B Delatycki
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

3.  A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model.

Authors:  Piyush M Vyas; Wendy J Tomamichel; P Melanie Pride; Clifford M Babbey; Qiujuan Wang; Jennifer Mercier; Elizabeth M Martin; R Mark Payne
Journal:  Hum Mol Genet       Date:  2011-11-23       Impact factor: 6.150

Review 4.  Cardiomyopathy in Friedreich ataxia: clinical findings and research.

Authors:  R Mark Payne; Gregory R Wagner
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

Review 5.  Clinical features of Friedreich ataxia.

Authors:  Martin B Delatycki; Louise A Corben
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

6.  Left ventricular long axis tissue Doppler systolic velocity is independently related to heart rate and body size.

Authors:  Roger E Peverill; Bon Chou; Lesley Donelan
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

7.  Left ventricular structural and functional changes in Friedreich ataxia - Relationship with body size, sex, age and genetic severity.

Authors:  Roger E Peverill; Giovanni Romanelli; Lesley Donelan; Rhonda Hassam; Louise A Corben; Martin B Delatycki
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

8.  Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency.

Authors:  Duncan E Crombie; Claire L Curl; Antonia Ja Raaijmakers; Priyadharshini Sivakumaran; Tejal Kulkarni; Raymond Cb Wong; Itsunari Minami; Marguerite V Evans-Galea; Shiang Y Lim; Lea Delbridge; Louise A Corben; Mirella Dottori; Norio Nakatsuji; Ian A Trounce; Alex W Hewitt; Martin B Delatycki; Martin F Pera; Alice Pébay
Journal:  Aging (Albany NY)       Date:  2017-05-30       Impact factor: 5.682

Review 9.  Heart disease in Friedreich's ataxia.

Authors:  Emily Hanson; Mark Sheldon; Brenda Pacheco; Mohammed Alkubeysi; Veena Raizada
Journal:  World J Cardiol       Date:  2019-01-26

10.  Differences in the determinants of right ventricular and regional left ventricular long-axis dysfunction in Friedreich ataxia.

Authors:  Roger E Peverill; Lesley Donelan; Louise A Corben; Martin B Delatycki
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.